22nd Century Group Inc (XXII) is around the middle of the Drug Manufacturers - Specialty & Generic industry according to InvestorsObserver. XXII received an overall rating of 34, which means that it scores higher than 34 percent of all stocks. 22nd Century Group Inc also achieved a score of 49 in the Drug Manufacturers - Specialty & Generic industry, putting it above 49 percent of Drug Manufacturers - Specialty & Generic stocks. Drug Manufacturers - Specialty & Generic is ranked 122 out of the 148 industries.
XXII has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on XXII!